ACTL6A and hepatocellular carcinoma: Overexpression of Baf53a in hepatocellular carcinoma was correlated with poor prognosis and metastasis47; expression of Baf53a in rhabdomyosarcoma was significantly higher than in normal muscle; suppression of Baf53a expression in rhabdomyosarcoma cells was associated with reduced proliferation48; and somatic mutation in the Baf53a gene was found in medulloblastomas49.